Veterinary Anti-Infectives Market Size, Share, Trends, Growth and Forecast 2032

Table Of Content

Methodology

Free Analysis

Anti-infectives are chemical substances capable of combating malfunction caused due to foreign bacteria such as Corona and Salmonella. These substances act in order to inhibit, prevent, and completely cure bacterial animal infections. Application of biological anti-infective makes the animal’s body immune from a particular bacterial infection, and also prevents future chances of contracting the infection. Veterinary pharmaceutical companies offer various products such as antibiotics, vaccines, parasiticides, medical feed additives and others. Of all product types, anti-infective formulations are more used by veterinary doctors. In recent years, studies have shown how fatal veterinary diseases are not limited to wild species, but may also occur in domestic animals. Increasing incidence of zoonotic and food-borne disorders and the need of mitigating such diseases is projected to render an exponential growth for veterinary therapeutics, including veterinary anti-infectives drug market.

Specialty and biologic care are offering huge investment opportunities for key players in anti-infectives market. Due to the aged product portfolio, the market anticipates NPD (New Product Development) in urgency. Entry of new market players and launch of abridged formulations, followed by changing distribution channels, a considerable rise in pet insurance, and competitive branded products for animal health care are collectively observed as key facets in this market. Improvised research & development methods in biologics will provide a huge array of opportunities in the market. Availability of generic drugs at affordable prices and increased end-user awareness for pet care is also offering significant growth opportunities for the veterinary anti-infective market.

Based on species type, veterinary anti-infectives market has been segmented into livestock and companion animals. On the basis of drug type, the market for veterinary anti-infectives is segmented into antimicrobial, antiviral, antifungal and antiparasitic agents. By mode of administration, the market for veterinary anti-infectives is segmented into oral, parenteral and topical. Based on end-user the veterinary anti-infectives market is segmented into veterinary hospitals, veterinary clinics, pharmacies and others.  

Increasing pet ownership and vigorous demand for improved animal nutrition are fueling the veterinary anti-infective market in North America. Balancing the animal’s nutrition with use of anti-infectives has proven to improve the immunity of animals, and help them in gaining resistance against most infections. In North America, people are more concerned about the health of their pet animal or livestock, so their focus on food safety, which is another influencing factor associated with higher nutritional demand in the global market for veterinary anti-infectives. Owing to high awareness, end-users continue to prefer drugs that are FDA-approved. Newly-launched generic drugs are estimated to increase market share for anti-infectives in the Asia Pacific. Moreover, the presence of generic companies and increasing level of disposable income is also expected to fuel the market’s growth further in this region.

Some of the key players in Veterinary Anti-Infectives market include ACG Worldwide, Bright Pharma Caps, Inc., CapsCanada, Capsugel, Healthcaps India Ltd., Qualicaps LLC, Suheung Co., Ltd. and Sunil Healthcare Limited. Investments in R&D and new manufacturing units for veterinary anti-infectives in economically stable countries and acquisitions and collaborations with manufacturers in different regions are other key differentiating strategies of the leading market players.